Portfolio Holdings Detail for ISIN IE00BHZPJ569

Stock Name / Fund	iShares MSCI World ESG Enhanced UCITS ETF USD Acc GBP
Issuer	Blackrock
Entity holding fund	iShares IV Public Limited Company
Entity Type
Entity LEI	549300ZP07LMR36K1T02
ETF Ticker	EGMW(GBP) LSE
ETF Ticker	EDMWx(GBP) CXE
ETF Ticker	ENWD.MI(EUR) CXE
ETF Ticker	ENWD(EUR) ETF Plus
ETF Ticker	EGMW.L(GBP) LSE

Holdings detail for MRK

Show aggregate MRK holdings

News associated with MRK

Surprising Analyst 12-Month Target For FDL

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-09-22 08:04:45

IWD, JNJ, MCD, MRK: Large Inflows Detected at ETF

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Russell 1000 Value ETF (Symbol: IWD) where we have detected an approximate $565.9 million dollar inflow -- that's a 0.9% increase week over w - 2025-09-18 13:26:06

Daiichi Sankyo, Merck Say Raludotatug Deruxtecan Granted Breakthrough Therapy Designation

(RTTNews) - Daiichi Sankyo Company Limited (DSKYF) and Merck & Co Inc. (MRK) said on Monday that the U.S. Food and Drug Administration (FDA) has granted breakthrough therapy designation for their raludotatug deruxtecan for the treatment of adults with platinum-resistant epithelia - 2025-09-15 08:43:59

Peter Lynch Detailed Fundamental Analysis - MRK

Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-09-12 10:32:51

Guru Fundamental Report for MRK - Peter Lynch

Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-09-11 10:33:21

Notable ETF Inflow Detected - VYM, JNJ, MRK, CME

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Vanguard High Dividend Yield ETF (Symbol: VYM) where we have detected an approximate $440.7 million dollar inflow -- that's a 0.7% increase week over - 2025-09-10 11:50:46

MRK Factor-Based Stock Analysis - Peter Lynch

Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-09-10 10:34:14

Daiichi Sankyo And Merck : Ifinatamab Deruxtecan Shows Promising Results In Phase 2 ES-SCLC Trial

(RTTNews) - Daiichi Sankyo (DSKYF, 4568.T) and Merck & Co Inc. (MRK) announced that Results from the IDeate-Lung01 phase 2 trial showed that ifinatamab deruxtecan (I-DXd) demonstrated clinically meaningful response rates in patients with previously treated extensive-stage small c - 2025-09-08 02:18:22

Peter Lynch Detailed Fundamental Analysis - MRK

Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-09-05 10:33:56

Pre-Market Most Active for Sep 5, 2025 : OPEN, TSLL, SCAG, SQQQ, MRK, NVDA, KO, AVGO, SNAP, FIG, WMT, NIO

The NASDAQ 100 Pre-Market Indicator is up 147.96 to 23,780.97. The total Pre-Market volume is currently 100,628,631 shares traded.The following are the most active stocks for the pre-market session: Opendoor Technologies Inc (OPEN) is +0.27 at $6.23, with 12,819,663 shares trade - 2025-09-05 09:29:53

Guru Fundamental Report for MRK - Peter Lynch

Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-09-04 10:32:25

MRK Factor-Based Stock Analysis - Peter Lynch

Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-09-03 10:34:47

Peter Lynch Detailed Fundamental Analysis - MRK

Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-08-29 10:33:23

MRK's Strong Dividend History Helps it Reach 'Top Dividend Stock of the Dow'

Merck & Co Inc (Symbol: MRK) has been named as the ''Top Dividend Stock of the Dow'', according to Dividend Channel, which published its most recent ''DividendRank'' report. The report noted that among the components of the Dow Jones Industrial Average, MRK shares displayed b - 2025-08-28 08:50:04

MRK Factor-Based Stock Analysis - Peter Lynch

Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-08-27 10:34:49

MRK Quantitative Stock Analysis - Peter Lynch

Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-08-26 10:34:02

iShares MSCI ACWI ETF Experiences Big Outflow

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares MSCI ACWI ETF (Symbol: ACWI) where we have detected an approximate $429.5 million dollar outflow -- that's a 1.9% decrease week over week (f - 2025-08-25 13:36:45

Peter Lynch Detailed Fundamental Analysis - MRK

Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-08-22 10:34:21

Dow Movers: WMT, MRK

In early trading on Thursday, shares of Merck topped the list of the day's best performing Dow Jones Industrial Average components, trading up 1.2%. Year to date, Merck has lost about 13.8% of its value. And the worst performing Dow component thus far on the day is Walmart, tr - 2025-08-21 11:27:42

MRK Factor-Based Stock Analysis - Peter Lynch

Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-08-20 10:34:00

After Hours Most Active for Aug 19, 2025 : CSX, INTC, MRK, NVDA, IBN, KO, FUN, PEP, CX, WMT, HTZ, QQQ

The NASDAQ 100 After Hours Indicator is down -1.71 to 23,383.06. The total After hours volume is currently 259,932,235 shares traded.The following are the most active stocks for the after hours session: CSX Corporation (CSX) is -0.04 at $36.48, with 11,794,785 shares traded. Ove - 2025-08-19 17:24:59

Daiichi Sankyo Announces Breakthrough Therapy Designation For Ifinatamab Deruxtecan

(RTTNews) - Daiichi Sankyo announced that Ifinatamab deruxtecan has been granted Breakthrough Therapy Designation by the FDA for the treatment of adult patients with extensive-stage small cell lung cancer with disease progression on or after platinum-based chemotherapy. The FDA g - 2025-08-18 08:36:51

The Zacks Analyst Blog Highlights Merck, Palo Alto Networks, Freeport-McMoRan and Espey

Analysts spotlight Merck, Palo Alto Networks, Freeport-McMoRan, and Espey as innovation, contract wins, and industry trends shape growth prospects. - 2025-08-15 12:44:00

Noteworthy ETF Outflows: SUSL, MCD, DIS, MRK

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares ESG MSCI USA Leaders ETF (Symbol: SUSL) where we have detected an approximate $84.6 million dollar outflow -- that's a 8.7% decrease week ov - 2025-08-15 11:49:25

Peter Lynch Detailed Fundamental Analysis - MRK

Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-08-15 10:31:59

Top Analyst Reports for Merck, Palo Alto & Freeport

Merck leans on Keytruda growth and pipeline expansion, Palo Alto rides subscription security demand, and Freeport benefits from electrification-driven copper demand. - 2025-08-14 17:46:00

Stocks See Support As Bessent Calls for a Big Rate Cut

The S&P 500 Index ($SPX ) (SPY ) on Wednesday rose +0.32%, the Dow Jones Industrials Index ($DOWI ) (DIA ) rose +1.04%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) rose +0.04%. September E-mini S&P futures (ESU25 ) rose +0.32%, and September E-mini Nasdaq futures (NQU25 ) fell... - 2025-08-14 15:15:33

MRK April 2026 Options Begin Trading

Investors in Merck & Co Inc (Symbol: MRK) saw new options become available today, for the April 2026 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 246 days until expiration the newly available contra - 2025-08-14 14:30:24

Stocks See Support As Bessent Calls for a Big Rate Cut

The S&P 500 Index ($SPX ) (SPY ) on Wednesday rose +0.32%, the Dow Jones Industrials Index ($DOWI ) (DIA ) rose +1.04%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) rose +0.04%. September E-mini S&P futures (ESU25 ) rose +0.32%, and September E-mini Nasdaq futures (NQU25 ) fell... - 2025-08-14 14:05:26

Stocks See Support As Bessent Calls for a Big Rate Cut

The S&P 500 Index ($SPX ) (SPY ) on Wednesday rose +0.32%, the Dow Jones Industrials Index ($DOWI ) (DIA ) rose +1.04%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) rose +0.04%. September E-mini S&P futures (ESU25 ) rose +0.32%, and September E-mini Nasdaq futures (NQU25 ) fell... - 2025-08-14 12:17:47

iShares MSCI World ESG Enhanced UCITS ETF USD Acc GBP MRK holdings

Date	Number of MRK Shares Held	Base Market Value of MRK Shares	Local Market Value of MRK Shares	Change in MRK Shares Held	Change in MRK Base Value	Current Price per MRK Share Held	Previous Price per MRK Share Held
2025-11-13 (Thursday)	226,870	USD 21,083,029	USD 21,083,029
2025-11-10 (Monday)	228,785	USD 19,847,099	USD 19,847,099	1,149	USD 320,483	USD 86.75	USD 85.78
2025-11-06 (Thursday)	227,636	USD 19,526,616	USD 19,526,616	0	USD 316,414	USD 85.78	USD 84.39
2025-11-05 (Wednesday)	227,636	USD 19,210,202	USD 19,210,202	2,681	USD 653,664	USD 84.39	USD 82.49
2025-11-03 (Monday)	224,955	USD 18,556,538	USD 18,556,538	0	USD -785,093	USD 82.49	USD 85.98
2025-10-31 (Friday)	224,955	USD 19,341,631	USD 19,341,631	0	USD -134,973	USD 85.98	USD 86.58
2025-10-29 (Wednesday)	224,955	USD 19,476,604	USD 19,476,604	0	USD -101,230	USD 86.58	USD 87.03
2025-10-28 (Tuesday)	224,955	USD 19,577,834	USD 19,577,834	0	USD -218,206	USD 87.03	USD 88
2025-10-27 (Monday)	224,955	USD 19,796,040	USD 19,796,040	-1,915	USD 17,513	USD 88	USD 87.18

Share Trades of MRK by Blackrock for IE00BHZPJ569

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-11-10	BUY	1,149	87.370	85.800	85.957	GBX 98,765	88.62
2025-11-05	BUY	2,681	85.380	82.912	83.159	GBX 222,948	88.66
2025-10-27	SELL	-1,915	88.295	87.030	87.157	GBX -166,905	88.72 Profit of 2,997 on sale
2025-10-21	SELL	-1,149	87.670	86.230	86.374	GBX -99,244	88.74 Profit of 2,720 on sale
2025-10-15	BUY	6,894	84.690	83.610	83.718	GBX 577,152	88.81
2025-10-03	SELL	-2,292	90.700	88.100	88.360	GBX -202,521	88.83 Profit of 1,078 on sale
2025-10-02	BUY	362	91.000	88.220	88.498	GBX 32,036	88.83
2025-10-01	BUY	5,100	90.750	85.190	85.746	GBX 437,305	88.82
2025-09-26	BUY	1,083	78.960	77.694	77.821	GBX 84,280	88.96
2025-09-24	SELL	-2,300	80.115	79.330	79.409	GBX -182,640	89.07 Profit of 22,222 on sale
2025-07-24	BUY	3,580	84.510	83.520	83.619	GBX 299,356	89.31
2025-07-23	BUY	1,436	84.140	82.410	82.583	GBX 118,589	89.34
2025-07-16	BUY	360	82.640	81.460	81.578	GBX 29,368	89.52
2025-07-10	SELL	-1,705	85.000	83.170	83.353	GBX -142,117	89.68 Profit of 10,783 on sale
2025-07-02	BUY	718	82.790	81.894	81.983	GBX 58,864	89.97
2025-06-02	SELL	-1,440			76.250*		91.56 Profit of 131,852 on sale
2025-05-30	BUY	31,957			76.840*		91.67
2025-05-29	SELL	-924			76.400*		91.78 Profit of 84,805 on sale
2025-05-28	SELL	-308	77.725	75.590	75.803	GBX -23,347	91.89 Profit of 4,956 on sale
2025-05-22	SELL	-4,605	78.360	76.680	76.848	GBX -353,885	92.32 Profit of 71,262 on sale
2025-05-16	BUY	586	76.165	74.368	74.547	GBX 43,685	92.80
2025-05-14	BUY	921			73.470*		93.09
2025-05-13	BUY	5,219			76.630*		93.22
2025-05-12	SELL	-307			80.430*		93.32 Profit of 28,650 on sale
2025-04-23	SELL	-614	80.200	78.240	78.436	GBX -48,160	94.73 Profit of 10,005 on sale
2025-04-22	SELL	-3,070	79.035	77.660	77.798	GBX -238,838	94.87 Profit of 52,423 on sale
2025-04-11	BUY	584	79.440	76.360	76.668	GBX 44,774	96.00
2025-04-09	BUY	584	81.990	76.000	76.599	GBX 44,734	96.32
2025-04-08	SELL	-1,475	83.270	77.540	78.113	GBX -115,217	96.49 Profit of 27,106 on sale
2025-04-07	SELL	-2,089	83.210	79.300	79.691	GBX -166,475	96.64 Profit of 35,413 on sale
2025-04-04	BUY	307	86.260	81.090	81.607	GBX 25,053	96.80
2025-03-27	BUY	1,228			87.600*		97.26
2025-03-11	BUY	7,650			94.730*		97.87
2025-03-07	BUY	612			94.650*		97.95
2025-03-06	BUY	584			94.000*		98.00
2025-03-03	SELL	-1,168	92.790	91.810	91.908	GBX -107,349	98.19 Profit of 7,342 on sale
2025-02-28	BUY	6,530	92.350	90.710	90.874	GBX 593,407	98.27
2025-02-26	BUY	11,521	91.370	88.860	89.111	GBX 1,026,648	98.50
2025-02-18	SELL	-7,938	83.590	81.040	81.295	GBX -645,320	99.43 Profit of 143,947 on sale
2025-02-13	BUY	1,120	85.690	84.310	84.448	GBX 94,582	100.18
2024-12-10	BUY	100,005	103.770	100.750	101.052	GBX 10,105,705	102.34
2024-12-09	BUY	588	105.070	102.330	102.604	GBX 60,331	102.31
2024-12-04	SELL	-1,470	102.090	101.050	101.154	GBX -148,696	102.29 Profit of 1,669 on sale
2024-12-03	SELL	-6,468	102.450	100.620	100.803	GBX -651,994	102.30 Profit of 9,681 on sale
2024-11-25	SELL	-56,013	101.740	99.510	99.733	GBX -5,586,345	102.39 Profit of 148,764 on sale
2024-11-19	SELL	-383	97.550	95.260	95.489	GBX -36,572	102.91 Profit of 2,841 on sale
2024-11-18	SELL	-400	97.290	95.420	95.607	GBX -38,243	103.11 Profit of 3,001 on sale
2024-11-12	BUY	1,200	100.760	98.500	98.726	GBX 118,471	103.26
2024-11-01	SELL	-3,200	102.720	101.210	101.361	GBX -324,355	104.75 Profit of 10,833 on sale
2024-11-01	SELL	-3,200	102.720	101.210	101.361	GBX -324,355	104.75 Profit of 10,833 on sale

Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of MRK

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer